WisdomTree BioRevolution Fund (BATS:WDNA – Get Free Report) rose 0.9% during mid-day trading on Monday . The stock traded as high as $19.05 and last traded at $19.03. 2,650 shares were traded during mid-day trading, an increase of 226% from the average daily volume of 814 shares. The stock had previously closed at $18.86.
WisdomTree BioRevolution Fund Price Performance
The firm has a 50-day simple moving average of $18.02 and a 200 day simple moving average of $17.79. The company has a market capitalization of $2.94 million, a PE ratio of 17.03 and a beta of 1.01.
Institutional Investors Weigh In On WisdomTree BioRevolution Fund
A hedge fund recently raised its stake in WisdomTree BioRevolution Fund stock. Jane Street Group LLC lifted its stake in shares of WisdomTree BioRevolution Fund (BATS:WDNA – Free Report) by 45.9% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,864 shares of the company’s stock after buying an additional 5,306 shares during the quarter. Jane Street Group LLC owned approximately 11.24% of WisdomTree BioRevolution Fund worth $231,000 as of its most recent filing with the Securities and Exchange Commission.
WisdomTree BioRevolution Fund Company Profile
The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.
Recommended Stories
- Five stocks we like better than WisdomTree BioRevolution Fund
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.
